# Body Composition Monitor in Hemodialysis Patients

Study · id `cardio:ct-nct01103167` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01103167](<https://clinicaltrials.gov/study/NCT01103167>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01103167

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

## Technical summary

Registry record NCT01103167. Allocation not applicable; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2010-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT01103167, source copy `cardio:ctgov-nct01103167-2010-04-14`, retrieved 2026-10-26)
- Start date: 2010-04 (registry gives no type) (ClinicalTrials.gov record NCT01103167, source copy `cardio:ctgov-nct01103167-2010-04-14`, retrieved 2026-10-26)
- Primary completion: 2010-10 (anticipated) (ClinicalTrials.gov record NCT01103167, source copy `cardio:ctgov-nct01103167-2010-04-14`, retrieved 2026-10-26)
- Completion: 2010-12 (anticipated) (ClinicalTrials.gov record NCT01103167, source copy `cardio:ctgov-nct01103167-2010-04-14`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01103167, source copy `cardio:ctgov-nct01103167-2010-04-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01103167-2010-04-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Body Composition Monitor in Hemodialysis Patients
- Condition: End Stage Renal Disease
- Intervention (Behavioral): control of ultrafiltration
- Lead sponsor: Gachon University Gil Medical Center
- Lead sponsor class: OTHER
- Collaborator: Seoul National University Hospital
- Collaborator class: OTHER
- Collaborator: Seoul National University Bundang Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Gachon University Gil Medical Center (`cardio:org-gachon-university-gil-medical-center`)
- Registry lists this organization as a collaborator: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)
- Registry lists this organization as a collaborator: Seoul National University Bundang Hospital (`cardio:org-seoul-national-university-bundang-hospital`)

## Provenance

Content hash: 82cb56c674aa50a5d90cff3c15a5dea1aa78d4305ae46db714242c1fd33f737a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
